Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response

Antonello Silvestri; Otavio Gebara; Cristiana Vitale; Mauricio Wajngarten; Filippo Leonardo; Josè A F Ramires; Massimo Fini; Giuseppe Mercuro; Giuseppe M C Rosano

doi:10.1161/01.CIR.0000074208.02226.5E

Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response

Antonello Silvestri, Otavio Gebara, Cristiana Vitale, Mauricio Wajngarten, Filippo Leonardo, Josè A F Ramires, Massimo Fini, Giuseppe Mercuro, Giuseppe M C Rosano

Istituto San Raffaele Pisana

Research output: Contribution to journal › Article › peer-review

Abstract

Background - It has been suggested that hormone replacement therapy (HRT) in postmenopausal women is associated with an increased inflammatory response that may trigger acute cardiovascular events. This suggestion is mainly based on the finding of elevated C-reactive protein (CRP) levels after HRT. The aim of the present study was to evaluate a broad spectrum of vascular inflammation markers in 389 postmenopausal women with increased cardiovascular risk at baseline and after either 6 months of HRT (126 women) or no HRT (263 women). Methods and Results - Compared with baseline, CRP levels significantly increased after HRT (0.9±0.2 versus 1.6±0.4 mg/L, P

Original language	English
Pages (from-to)	3165-3169
Number of pages	5
Journal	Circulation
Volume	107
Issue number	25
DOIs	https://doi.org/10.1161/01.CIR.0000074208.02226.5E
Publication status	Published - Jul 1 2003

Keywords

Cardiovascular diseases
Inflammation
Interleukins

ASJC Scopus subject areas

Physiology
Cardiology and Cardiovascular Medicine

Access to Document

10.1161/01.CIR.0000074208.02226.5E

Cite this

@article{5eeb6922666244f6a75239b6c8182b5d,

title = "Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response",

abstract = "Background - It has been suggested that hormone replacement therapy (HRT) in postmenopausal women is associated with an increased inflammatory response that may trigger acute cardiovascular events. This suggestion is mainly based on the finding of elevated C-reactive protein (CRP) levels after HRT. The aim of the present study was to evaluate a broad spectrum of vascular inflammation markers in 389 postmenopausal women with increased cardiovascular risk at baseline and after either 6 months of HRT (126 women) or no HRT (263 women). Methods and Results - Compared with baseline, CRP levels significantly increased after HRT (0.9±0.2 versus 1.6±0.4 mg/L, P",

keywords = "Cardiovascular diseases, Inflammation, Interleukins",

author = "Antonello Silvestri and Otavio Gebara and Cristiana Vitale and Mauricio Wajngarten and Filippo Leonardo and Ramires, {Jos{\`e} A F} and Massimo Fini and Giuseppe Mercuro and Rosano, {Giuseppe M C}",

year = "2003",

month = jul,

day = "1",

doi = "10.1161/01.CIR.0000074208.02226.5E",

language = "English",

volume = "107",

pages = "3165--3169",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "25",

}

TY - JOUR

T1 - Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response

AU - Silvestri, Antonello

AU - Gebara, Otavio

AU - Vitale, Cristiana

AU - Wajngarten, Mauricio

AU - Leonardo, Filippo

AU - Ramires, Josè A F

AU - Fini, Massimo

AU - Mercuro, Giuseppe

AU - Rosano, Giuseppe M C

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Background - It has been suggested that hormone replacement therapy (HRT) in postmenopausal women is associated with an increased inflammatory response that may trigger acute cardiovascular events. This suggestion is mainly based on the finding of elevated C-reactive protein (CRP) levels after HRT. The aim of the present study was to evaluate a broad spectrum of vascular inflammation markers in 389 postmenopausal women with increased cardiovascular risk at baseline and after either 6 months of HRT (126 women) or no HRT (263 women). Methods and Results - Compared with baseline, CRP levels significantly increased after HRT (0.9±0.2 versus 1.6±0.4 mg/L, P

AB - Background - It has been suggested that hormone replacement therapy (HRT) in postmenopausal women is associated with an increased inflammatory response that may trigger acute cardiovascular events. This suggestion is mainly based on the finding of elevated C-reactive protein (CRP) levels after HRT. The aim of the present study was to evaluate a broad spectrum of vascular inflammation markers in 389 postmenopausal women with increased cardiovascular risk at baseline and after either 6 months of HRT (126 women) or no HRT (263 women). Methods and Results - Compared with baseline, CRP levels significantly increased after HRT (0.9±0.2 versus 1.6±0.4 mg/L, P

KW - Cardiovascular diseases

KW - Inflammation

KW - Interleukins

UR - http://www.scopus.com/inward/record.url?scp=0038417544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038417544&partnerID=8YFLogxK

U2 - 10.1161/01.CIR.0000074208.02226.5E

DO - 10.1161/01.CIR.0000074208.02226.5E

M3 - Article

C2 - 12796135

AN - SCOPUS:0038417544

VL - 107

SP - 3165

EP - 3169

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 25

ER -

Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this